Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Recent Japanese patent reveals new TNF-alpha inhibitors from Snow Brand

Dec. 13, 2000

Health Canada clears Enbrel for moderately to severely active RA

Dec. 13, 2000

Pyrazole-based antiinflammatory agents patented by Dr. Reddy's team

Dec. 11, 2000

Dimethaid receives approval for Pennsaid lotion in U.K.

Dec. 11, 2000

Integrin alpha4beta1 inhibitors disclosed by AstraZeneca scientists

Nov. 29, 2000

Hydroxamic acid-based MMP inhibitors discovered by Sumitomo team

Nov. 28, 2000

Preparation and use of new MMP/TNF-alpha inhibitors described by Fujisawa

Nov. 28, 2000

Novel cyclic tyrosine kinase inhibitors reported by BMS scientists

Nov. 27, 2000

Phase II/III data, including subgroup analyses, on LJP-394 discussed at ACR meeting

Nov. 24, 2000

Santen presents novel urea TNF-alpha production inhibitors

Nov. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...